A Literature Review Examining Primary Outcomes of Medication Treatment Studies for Opioid Use Disorder: What Outcome Should Be Used to Measure Opioid Treatment Success?-Reference-Cited by-同舟云学术

A Literature Review Examining Primary Outcomes of Medication Treatment Studies for Opioid Use Disorder: What Outcome Should Be Used to Measure Opioid Treatment Success?

Published:2020-04-29 Issue:4 Volume:29 Page:249-267
ISSN:1055-0496
Container-title:The American Journal on Addictions
language:en
Short-container-title:Am J Addict

Author:

Biondi Breanne E.¹^ORCID,Zheng Xiaoying²,Frank Cynthia A.¹,Petrakis Ismene³⁴^ORCID,Springer Sandra A.¹⁴⁵

Affiliation:

1. Department of Internal MedicineSection of Infectious Diseases, AIDS Program New Haven Connecticut

2. Yale University New Haven Connecticut

3. Department of PsychiatryYale School of Medicine New Haven Connecticut

4. Veterans Administration Connecticut Healthcare Services West Haven Connecticut

5. Center for Interdisciplinary Research on AIDS, Yale University School of Public Health New Haven Connecticut

Funder

National Institute on Drug Abuse

Publisher

Wiley

Subject

Psychiatry and Mental health,Clinical Psychology,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajad.13051

Reference49 articles.

1. Today's Heroin Epidemic Infographics;2015.https://www.cdc.gov/vitalsigns/heroin/infographic.html. Accessed 4 June 2019.

2. Centers for Disease Control and Prevention. 2019 annual surveillance report of drug‐related risks and outcomes—United States surveillance special report. Centers for Disease Control and Prevention U.S. Department of Health and Human Services;2019.https://www.cdc.gov/drugoverdose/pdf/pubs/2019‐cdc‐drug‐surveillancereport.pdf. Accessed December 2019.

3. A Brief History of the Opioid Epidemic and Strategies for Pain Medicine

4. National Institutes of Health. HEAL Initiative Research Plan.https://www.nih.gov/research‐training/medical‐research‐initiatives/heal‐initiative/heal‐initiative‐research‐plan. Accessed September 2019.

5. Food and Drug Administration. FDA approves first buprenorphine implant for treatment of opioid dependence. FDA News Release 2016;2016.https://www.fda.gov/news‐events/press‐announcements/fda‐approves‐first‐buprenorphine‐implant‐treatment‐opioid‐dependence. Accessed 4 June2019.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Self-help groups and opioid use disorder treatment: An investigation using a machine learning-assisted robust causal inference framework;International Journal of Medical Informatics;2024-10

2. Worsening trends in the frequency of methamphetamine and other stimulant use between treatment admission and discharge;Drug and Alcohol Dependence;2024-09

3. Buprenorphine-naloxone vs. extended-release naltrexone for opioid use disorder in individuals with and without criminal legal involvement: A secondary analysis of the X:BOT randomized controlled trial;Journal of Substance Use and Addiction Treatment;2024-09

4. Mediating effect of craving on the impact of buprenorphine/naloxone and methadone treatment on opioid use: Results from a randomized controlled trial;Addictive Behaviors;2024-07

5. Empirically contrasting urine drug screening‐based opioid use disorder treatment outcome definitions;Addiction;2024-04-14